A Study With an Open-label Extension Phase to Evaluate the Efficacy and Safety of Perampanel (E2007) Administered as an Adjunctive Therapy in Subjects With Refractory Partial-onset Seizures
Clinical trial NCT01618695 · COMPLETED
Trial details
- NCT number
- NCT01618695
- Sponsor
- Eisai Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2012-05-15
- Primary completion
- 2014-09-15
- Enrollment
- 940
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.